• Je něco špatně v tomto záznamu ?

Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS

T. Kalincik, I. Kister, TE. Bacon, CB. Malpas, S. Sharmin, D. Horakova, E. Kubala-Havrdova, F. Patti, G. Izquierdo, S. Eichau, S. Ozakbas, M. Onofrj, A. Lugaresi, A. Prat, M. Girard, P. Duquette, P. Grammond, P. Sola, D. Ferraro, R. Alroughani,...

. 2022 ; 28 (11) : 1752-1761. [pub] 20220403

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22024305

BACKGROUND: The MSBase prediction model of treatment response leverages multiple demographic and clinical characteristics to estimate hazards of relapses, confirmed disability accumulation (CDA), and confirmed disability improvement (CDI). The model did not include Multiple Sclerosis Severity Score (MSSS), a disease duration-adjusted ranked score of disability. OBJECTIVE: To incorporate MSSS into the MSBase prediction model and compare model accuracy with and without MSSS. METHODS: The associations between MSSS and relapse, CDA, and CDI were evaluated with marginal proportional hazards models adjusted for three principal components representative of patients' demographic and clinical characteristics. The model fit with and without MSSS was assessed with penalized r2 and Harrell C. RESULTS: A total of 5866 MS patients were started on disease-modifying therapy during prospective follow-up (age 38.4 ± 10.6 years; 72% female; disease duration 8.5 ± 7.7 years). Including MSSS into the model improved the accuracy of individual prediction of relapses by 31%, of CDA by 23%, and of CDI by 24% (Harrell C) and increased the amount of variance explained for relapses by 49%, for CDI by 11%, and for CDA by 10% as compared with the original model. CONCLUSION: Addition of a single, readily available metric, MSSS, to the comprehensive MSBase prediction model considerably improved the individual accuracy of prognostics in MS.

Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino Avellino Italy

Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases Istanbul Turkey

Central Clinical School Monash University Melbourne VIC Australia

CISSS Chaudi're Appalache Levis QC Canada

Cliniques Universitaires Saint Luc UCLouvain Brussels Belgium

CORe Department of Medicine The University of Melbourne Melbourne VIC Australia MS Centre Department of Neurology The Royal Melbourne Hospital Melbourne VIC Australia

CSSS Saint Jérôme Saint Jerome QC Canada

Department of Biostatistics UAB School of Public Health Birmingham AL USA

Department of Medicine and Surgery University of Parma Parma Italy

Department of Neurology Charles University Prague Prague Czech Republic

Department of Neurology Zuyderland Medical Centre Sittard Geleen The Netherlands School for Mental Health and Neuroscience Department of Neurology Maastricht University Medical Centre Maastricht The Netherlands

Department of Neuroscience Imaging and Clinical Sciences University G d'Annunzio Chieti Italy

Division of Neurology Department of Medicine Amiri Hospital Sharq Kuwait

Dokuz Eylul University Izmir Turkey

GF Ingrassia Department University of Catania Catania Italy

Haydarpasa Numune Training and Research Hospital Istanbul Turkey

Hospital S João Porto Portugal

Hospital Universitario Virgen Macarena Sevilla Spain

IRCCS Istituto delle Scienze Neurologiche di Bologna Bologna Italy Dipartimento di Scienze Biomediche e Neuromotorie Università di Bologna Bologna Italy

IRCCS Mondino Foundation Pavia Italy

Isfahan University of Medical Sciences Isfahan Islamic Republic of Iran

KTU Medical Faculty Farabi Hospital Trabzon Turkey

Medical Faculty 19 Mayis University Samsun Turkey

Nemocnice Jihlava Jihlava Czech Republic

Neuro Rive Sud Greenfield Park QC Canada

Neurology NYU School of Medicine New York NY USA

Neurology Unit Department of Neuroscience Azienda Ospedaliera Universitaria Modena Italy

Neurology Unit Department of Neuroscience Azienda Ospedaliera Universitaria Modena Italy Department of Biomedical Metabolic and Neurosciences University of Modena and Reggio Emilia Modena Italy

Neurology Unit Piazza S Maria di Gesù 5 Catania Italy

Ospedali Riuniti di Salerno Salerno Italy

Research Center for Clinical Neuroimmunology and Neuroscience and MS Center Departments of Head Spine and Neuromedicine Clinical Research and Biomedicine University Hospital Basel University of Basel Basel Switzerland

School of Medicine and Public Health The University of Newcastle Newcastle NSW Australia

Universite de Montreal and CHUM Montreal QC Canada

University Fernando Pessoa Porto Portugal

UOC Neurologia Azienda Sanitaria Unica Regionale Marche AV3 Macerata Italy

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22024305
003      
CZ-PrNML
005      
20221031100303.0
007      
ta
008      
221017s2022 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1177/13524585221084577 $2 doi
035    __
$a (PubMed)35373638
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kalincik, Tomas $u CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia/MS Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia $1 https://orcid.org/0000000337781376
245    10
$a Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS / $c T. Kalincik, I. Kister, TE. Bacon, CB. Malpas, S. Sharmin, D. Horakova, E. Kubala-Havrdova, F. Patti, G. Izquierdo, S. Eichau, S. Ozakbas, M. Onofrj, A. Lugaresi, A. Prat, M. Girard, P. Duquette, P. Grammond, P. Sola, D. Ferraro, R. Alroughani, M. Terzi, C. Boz, F. Grand'Maison, R. Bergamaschi, O. Gerlach, MJ. Sa, L. Kappos, E. Cartechini, J. Lechner-Scott, V. van Pesch, V. Shaygannejad, F. Granella, D. Spitaleri, G. Iuliano, D. Maimone, J. Prevost, A. Soysal, R. Turkoglu, R. Ampapa, H. Butzkueven, G. Cutter, for MSBase Study Group
520    9_
$a BACKGROUND: The MSBase prediction model of treatment response leverages multiple demographic and clinical characteristics to estimate hazards of relapses, confirmed disability accumulation (CDA), and confirmed disability improvement (CDI). The model did not include Multiple Sclerosis Severity Score (MSSS), a disease duration-adjusted ranked score of disability. OBJECTIVE: To incorporate MSSS into the MSBase prediction model and compare model accuracy with and without MSSS. METHODS: The associations between MSSS and relapse, CDA, and CDI were evaluated with marginal proportional hazards models adjusted for three principal components representative of patients' demographic and clinical characteristics. The model fit with and without MSSS was assessed with penalized r2 and Harrell C. RESULTS: A total of 5866 MS patients were started on disease-modifying therapy during prospective follow-up (age 38.4 ± 10.6 years; 72% female; disease duration 8.5 ± 7.7 years). Including MSSS into the model improved the accuracy of individual prediction of relapses by 31%, of CDA by 23%, and of CDI by 24% (Harrell C) and increased the amount of variance explained for relapses by 49%, for CDI by 11%, and for CDA by 10% as compared with the original model. CONCLUSION: Addition of a single, readily available metric, MSSS, to the comprehensive MSBase prediction model considerably improved the individual accuracy of prognostics in MS.
650    _2
$a dospělí $7 D000328
650    _2
$a posuzování pracovní neschopnosti $7 D004185
650    _2
$a progrese nemoci $7 D018450
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a roztroušená skleróza $x diagnóza $7 D009103
650    _2
$a prospektivní studie $7 D011446
650    _2
$a recidiva $7 D012008
650    _2
$a stupeň závažnosti nemoci $7 D012720
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kister, Ilya $u Neurology, NYU School of Medicine, New York, NY, USA $1 https://orcid.org/000000033549949X
700    1_
$a Bacon, Tamar E $u Neurology, NYU School of Medicine, New York, NY, USA
700    1_
$a Malpas, Charles B $u CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia/MS Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia
700    1_
$a Sharmin, Sifat $u CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia/MS Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia
700    1_
$a Horakova, Dana $u Department of Neurology, Charles University in Prague, Prague, Czech Republic $1 https://orcid.org/0000000319150036
700    1_
$a Kubala-Havrdova, Eva $u Department of Neurology, Charles University in Prague, Prague, Czech Republic
700    1_
$a Patti, Francesco $u GF Ingrassia Department, University of Catania, Catania, Italy $1 https://orcid.org/0000000269230846
700    1_
$a Izquierdo, Guillermo $u Hospital Universitario Virgen Macarena, Sevilla, Spain
700    1_
$a Eichau, Sara $u Hospital Universitario Virgen Macarena, Sevilla, Spain $1 https://orcid.org/0000000191593128
700    1_
$a Ozakbas, Serkan $u Dokuz Eylul University, Izmir, Turkey
700    1_
$a Onofrj, Marco $u Department of Neuroscience, Imaging, and Clinical Sciences, University G. d'Annunzio, Chieti, Italy
700    1_
$a Lugaresi, Alessandra $u IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy/Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy $1 https://orcid.org/0000000329025589
700    1_
$a Prat, Alexandre $u Universite de Montreal and CHUM, Montreal, QC, Canada
700    1_
$a Girard, Marc $u Universite de Montreal and CHUM, Montreal, QC, Canada
700    1_
$a Duquette, Pierre $u Universite de Montreal and CHUM, Montreal, QC, Canada
700    1_
$a Grammond, Pierre $u CISSS Chaudi're-Appalache, Levis, QC, Canada
700    1_
$a Sola, Patrizia $u Neurology Unit, Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy
700    1_
$a Ferraro, Diana $u Neurology Unit, Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy/Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Modena, Italy
700    1_
$a Alroughani, Raed $u Division of Neurology, Department of Medicine, Amiri Hospital, Sharq, Kuwait $1 https://orcid.org/0000000154365804
700    1_
$a Terzi, Murat $u Medical Faculty, 19 Mayis University, Samsun, Turkey
700    1_
$a Boz, Cavit $u KTU Medical Faculty Farabi Hospital, Trabzon, Turkey
700    1_
$a Grand'Maison, Francois $u Neuro Rive-Sud, Greenfield Park, QC, Canada
700    1_
$a Bergamaschi, Roberto $u IRCCS Mondino Foundation, Pavia, Italy
700    1_
$a Gerlach, Oliver $u Department of Neurology, Zuyderland Medical Centre, Sittard-Geleen, The Netherlands/School for Mental Health and Neuroscience, Department of Neurology, Maastricht University Medical Centre, Maastricht, The Netherlands
700    1_
$a Sa, Maria J $u Hospital S. João, Porto, Portugal; University Fernando Pessoa, Porto, Portugal
700    1_
$a Kappos, Ludwig $u Research Center for Clinical Neuroimmunology and Neuroscience(RC2NB) and MS Center, Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland $1 https://orcid.org/0000000341755509
700    1_
$a Cartechini, Elisabetta $u UOC Neurologia, Azienda Sanitaria Unica Regionale Marche-AV3, Macerata, Italy
700    1_
$a Lechner-Scott, Jeannette $u School of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, Australia $1 https://orcid.org/000000023850447X
700    1_
$a van Pesch, Vincent $u Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium
700    1_
$a Shaygannejad, Vahid $u Isfahan University of Medical Sciences, Isfahan, Islamic Republic of Iran $1 https://orcid.org/0000000262260161
700    1_
$a Granella, Franco $u Department of Medicine and Surgery, University of Parma, Parma, Italy
700    1_
$a Spitaleri, Daniele $u Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino, Avellino, Italy
700    1_
$a Iuliano, Gerardo $u Ospedali Riuniti di Salerno, Salerno, Italy
700    1_
$a Maimone, Davide $u Neurology Unit, Piazza S. Maria di Gesù 5, Catania, Italy
700    1_
$a Prevost, Julie $u CSSS Saint-Jérôme, Saint-Jerome, QC, Canada
700    1_
$a Soysal, Aysun $u Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey
700    1_
$a Turkoglu, Recai $u Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey
700    1_
$a Ampapa, Radek $u Nemocnice Jihlava, Jihlava, Czech Republic
700    1_
$a Butzkueven, Helmut $u Central Clinical School, Monash University, Melbourne, VIC, Australia
700    1_
$a Cutter, Gary $u Department of Biostatistics, UAB School of Public Health, Birmingham, AL, USA
710    2_
$a for MSBase Study Group
773    0_
$w MED00006389 $t Multiple sclerosis $x 1477-0970 $g Roč. 28, č. 11 (2022), s. 1752-1761
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35373638 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031100301 $b ABA008
999    __
$a ok $b bmc $g 1854178 $s 1175595
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 28 $c 11 $d 1752-1761 $e 20220403 $i 1477-0970 $m Multiple sclerosis $n Mult Scler $x MED00006389
LZP    __
$a Pubmed-20221017

Najít záznam

Citační ukazatele

Možnosti archivace